![Dan Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Dan Liu is a Member-Supervisory Board at HitGen, Inc. He previously served as a Non-Executive Director at Wuhan YZY Biopharma Co., Ltd. Dr. Liu holds a doctorate degree from Vanderbilt University and Yale University, and an undergraduate degree from Nanjing University.
Precedenti posizioni note di Dan Liu
| Società | Posizione | Fine |
|---|---|---|
| HITGEN INC. | Direttore/Membro del Consiglio | 28/06/2024 |
| WUHAN YZY BIOPHARMA CO., LTD. | Direttore/Membro del Consiglio | 30/04/2024 |
Formazione di Dan Liu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
95
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
 Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HitGen, Inc.
 HitGen, Inc. BiotechnologyHealth Technology Develops innovative drugs | Health Technology |
Wuhan YZY Biopharma Co., Ltd.
 Wuhan YZY Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and commercializes immune-oncology therapies | Health Technology |
